We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$683M
AUM Growth
+$58.2M
(+9.3%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.97M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
BCPC
Balchem Corp
BCPC
|
+$2.09M |
| 4 |
Quest Diagnostics
DGX
|
+$1.56M |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.54M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.95M |
| 3 |
Comcast
CMCSA
|
+$1.76M |
| 4 |
CDW
CDW
|
+$1.48M |
| 5 |
Medtronic
MDT
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Johnson & Johnson
JNJ
$618B
| $2.13M | 0.31% |
13,932
+163
| +1% | +$25.1K |
|
102
Diamondback Energy
FANG
$57.1B
| $2.13M | 0.31% |
15,470
+292
| +2% | +$40.5K |
|
103
Air Products & Chemicals
APD
$65.7B
| $2.07M | 0.3% |
7,323
+60
| +0.8% | +$16.4K |
|
104
Ecolab
ECL
$78.1B
| $2.06M | 0.3% |
7,658
+309
| +4% | +$78.5K |
|
105
Pool Corp
POOL
$6.75B
| $2.06M | 0.3% |
7,072
-17
| -0.2% | -$5.14K |
|
106
SharkNinja
SN
$22.9B
| $2.03M | 0.3% |
20,488
+430
| +2% | +$37.2K |
|
|
107
CDW
CDW
$18.9B
| $1.95M | 0.29% |
10,898
-8,696
| -44% | -$1.48M |
|
108
Intercontinental Exchange
ICE
$85.6B
| $1.92M | 0.28% |
10,453
+476
| +5% | +$81.8K |
|
109
Jones Lang LaSalle
JLL
$16.3B
| $1.82M | 0.27% |
7,112
+113
| +2% | +$25.9K |
|
110
Robert Half
RHI
$3.87B
| $1.76M | 0.26% |
42,951
+710
| +2% | +$32.3K |
|
111
Roper Technologies
ROP
$38.8B
| $1.63M | 0.24% |
2,884
+118
| +4% | +$66.7K |
|
112
State Street
STT
$50.6B
| $1.63M | 0.24% |
15,315
-85
| -0.6% | -$7.86K |
|
113
Cisco
CSCO
$457B
| $1.62M | 0.24% |
23,362
+628
| +3% | +$38.6K |
|
114
RPM International
RPM
$13.7B
| $1.62M | 0.24% |
14,714
+374
| +3% | +$41.1K |
|
|
115
Quest Diagnostics
DGX
$25.7B
| $1.61M | 0.24% |
+8,980
| New | +$1.56M |
|
116
Revvity
RVTY
$12.6B
| $1.44M | 0.21% |
14,898
-327
| -2% | -$30.8K |
|
117
iShares Global REIT ETF
REET
$5.09B
| $1.44M | 0.21% |
58,100
| – | – |
|
118
US Bancorp
USB
$98.2B
| $1.42M | 0.21% |
31,467
+5
| +0% | +$210 |
|
119
Phillips 66
PSX
$84.9B
| $1.36M | 0.2% |
11,407
-74
| -0.6% | -$8.29K |
|
|
120
Thermo Fisher Scientific
TMO
$213B
| $1.31M | 0.19% |
3,235
-4,663
| -59% | -$1.95M |
|
121
Union Pacific
UNP
$174B
| $1.23M | 0.18% |
5,348
-205
| -4% | -$45.5K |
|
122
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $1.22M | 0.18% |
19,641
+5
| +0% | +$294 |
|
123
UnitedHealth
UNH
$376B
| $1.21M | 0.18% |
3,872
-449
| -10% | -$172K |
|
124
United Parcel Service
UPS
$88.6B
| $1.13M | 0.17% |
11,224
+106
| +1% | +$10.4K |
|
125
Tractor Supply
TSCO
$16.1B
| $1.12M | 0.16% |
21,257
+1,059
| +5% | +$54.2K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
- First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
- First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
- First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
- First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
- First National Advisers opened 14 new positions and closed 5 in Q2 2025.
- First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.
Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.